NASDAQ:LGVN

Longeveron Stock Forecast, Price & News

$6.92
+0.11 (+1.62 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.53
Now: $6.92
$7.02
50-Day Range
$5.66
MA: $6.99
$8.45
52-Week Range
$5.61
Now: $6.92
$12.48
Volume63,398 shs
Average Volume776,738 shs
Market Capitalization$129.45 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LGVN
CUSIPN/A
CIKN/A
Phone305 909 0840
Employees12
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$129.45 million
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Longeveron Inc
February 24, 2021 |  reuters.com
See More Headlines

MarketRank

Overall MarketRank

0.33 out of 5 stars

Medical Sector

1775th out of 2,011 stocks

Biotechnology Industry

114th out of 143 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
$6.92
+0.11 (+1.62 %)
(As of 04/12/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LGVN News and Ratings via Email

Sign-up to receive the latest news and ratings for LGVN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Longeveron (NASDAQ:LGVN) Frequently Asked Questions

What stocks does MarketBeat like better than Longeveron?

Wall Street analysts have given Longeveron a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Longeveron wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Longeveron's key executives?

Longeveron's management team includes the following people:
  • Dr. Joshua Michael Hare M.D., Co-Founder, Chief Science Officer & Chairman (Age 58, Pay $270k)
  • Mr. Geoff Green M.B.A., Chief Exec. Officer (Age 47, Pay $234.33k)
  • Mr. James Clavijo, CFO & Treasurer (Age 55, Pay $171.81k)
  • Mr. Paul T. Lehr J.D., International Exec. Director, Gen. Counsel & Sec. (Age 53, Pay $182.65k)
  • Dr. Anthony Oliva Ph.D., Sr. VP of Scientific Affairs (Age 50)

Who are some of Longeveron's key competitors?

When did Longeveron IPO?

(LGVN) raised $30 million in an IPO on Friday, February 12th 2021. The company issued 2,700,000 shares at a price of $10.00-$12.00 per share. Kingswood Capital Markets and Alexander Capital L.P. acted as the underwriters for the IPO.

What is Longeveron's stock symbol?

Longeveron trades on the NASDAQ under the ticker symbol "LGVN."

When does the company's lock-up period expire?

Longeveron's lock-up period expires on Wednesday, August 11th. Longeveron had issued 2,660,000 shares in its public offering on February 12th. The total size of the offering was $26,600,000 based on an initial share price of $10.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

How do I buy shares of Longeveron?

Shares of LGVN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Longeveron's stock price today?

One share of LGVN stock can currently be purchased for approximately $6.92.

How much money does Longeveron make?

Longeveron has a market capitalization of $129.45 million.

How many employees does Longeveron have?

Longeveron employs 12 workers across the globe.

What is Longeveron's official website?

The official website for Longeveron is www.longeveron.com.

How can I contact Longeveron?

The company can be reached via phone at 305 909 0840.


This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.